Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

The European Medicines Agency, EU's&nbsp;drug regulator has said that heart inflammation is a "very rare" side-effect of the Covid vaccines made by Pfizer and Moderna.
The European Medicines Agency said the side-effects were more common in younger men.&nbsp;The medicines safety body assured that the benefits of Covid vaccines continue to far outweigh any risks.&nbsp;But doctors and patients have been advised to be aware of the symptoms of heart inflammation.
Two conditions were linked to the vaccines - inflammation of the heart muscle itself, known as myocarditis, and inflammation of the fluid-filled sac the heart sits in, known as pericarditis.&nbsp;The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has also been investigating the link.

European Medicines Agency: Link between Pfizer, Moderna jabs and heart inflammation

European Medicines Agency says heart inflammation is "a very rare" side effect of the&nbsp;Pfizer, Moderna jabs&nbsp;

EMA&nbsp;flags possible side effect of Pfizer and Moderna&nbsp;Covid&nbsp;vaccine
Drug regulator says heart inflammation is a "very rare" side-effect
EMA: side-effects of vaccine were more common in younger men
Benefits of Covid vaccines continue to far outweigh any risks:&nbsp;EMA
Doctors and patients advised to be aware of the symptoms&nbsp;
Two conditions seen due to vaccine - myocarditis&nbsp;and&nbsp;pericarditis
UK's Medicines Regulatory Agency also probing link to both vaccines

The European Medicines Agency said the side-effects were more common in younger men.

The European Medicines Agency, EU's&nbsp;drug regulator has said that heart inflammation is a "very rare" side-effect of the Covid vaccines made by Pfizer and Moderna.
The European Medicines Agency said the side-effects were more common in younger men.&nbsp;The medicines safety body assured that the benefits of Covid vaccines continue to far outweigh any risks.&nbsp;But doctors and patients have been advised to be aware of the symptoms of heart inflammation.
Two conditions were linked to the vaccines - inflammation of the heart muscle itself, known as myocarditis, and inflammation of the fluid-filled sac the heart sits in, known as pericarditis.&nbsp;The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has also been investigating the link.

The European Union&rsquo;s drug watchdog on Friday approved the Pfizer/BioNTech&nbsp;coronavirus&nbsp;jab for 12 to 15-year-olds, becoming the first vaccine to get the green light for children in the bloc.&nbsp;Amsterdam-based European Medicines Agency said, the vaccine was &ldquo;well tolerated" in children and there were no &ldquo;major concerns" in terms of side effects. Germany has said it will start vaccinating children over the age of 12 from June 7 following the authorisation by the EMA.&nbsp;The United States and Canada have both already authorised the vaccine for children of the same age.

European Union's drug regulator approves Pfizer vaccine for 12 to 15 year olds

EU drug regulator approves Pfizer vaccine for children
12 to 15 year olds&nbsp;can receive the vaccine in the Europe
Pfizer vaccine first to get the nod for children in EU
EMA: vaccine well tolerated, so side-effects were seen
Germany to start vaccinating children from June 7
US and Canada have authorised Pfizer's jab for kids
&nbsp;

The European Union&rsquo;s drug watchdog on Friday approved the Pfizer/BioNTech&nbsp;coronavirus&nbsp;jab for 12 to 15-year-olds, becoming the first vaccine to get the green light for children in the bloc.&nbsp;Amsterdam-based European Medicines Agency said, the vaccine was &ldquo;well tolerated" in children and there were no &ldquo;major concerns" in terms of side effects. Germany has said it will start vaccinating children over the age of 12 from June 7 following the authorisation by the EMA.&nbsp;The United States and Canada have both already authorised the vaccine for children of the same age.

Four cases, one fatal, of rare clots with low blood platelets were reported among those vaccinated with the Johnson &amp; Johnson shot which has prompted the EU drug regulator to review the vaccine.&nbsp;The EMA has already approved the Johnson &amp; Johnson vaccine for use, but its rollout across the 27-nation EU is not due to start until later this month.
European Medicines Agency has also widened the probe on the&nbsp;AstraZenca&nbsp;jab after five cases reported a blood vessel leak which caused swelling and a drop in blood pressure after vaccination in recipients.

EU regulator puts J&J’s Covid vaccine under review after blood clots

Four cases, one fatal, of rare clots with low blood platelets were reported among those vaccinated with the Johnson &amp; Johnson shot which has prompted the EU drug regulator to review the vaccine.&nbsp;

<ul>
<li>European Medicines Agency puts J&amp;J vaccine under review&nbsp;</li>
<li>EMA: 4 cases, one fatal due to clots post J&amp;J vaccine</li>
<li>EMA&nbsp;has given the nod to J&amp;J but not started rollout yet</li>
<li>EU drug regulator widens probe on AstraZenca&nbsp;vaccine as well</li>
</ul>

Four cases, one fatal, of rare clots with low blood platelets were reported among those vaccinated with the Johnson &amp; Johnson shot which has prompted the EU drug regulator to review the vaccine.&nbsp; The EMA has already approved the Johnson &amp; Johnson vaccine for use, but its rollout across the 27-nation EU is not due to start until later this month.
European Medicines Agency has also widened the probe on the&nbsp;AstraZenca&nbsp;jab after five cases reported a blood vessel leak which caused swelling and a drop in blood pressure after vaccination in recipients.

european medicines agency

Categories